Head-To-Head Comparison: GeneDx (NASDAQ:WGS) & Ramsay Health Care (OTCMKTS:RMYHY)

GeneDx (NASDAQ:WGS) and Ramsay Health Care (OTCMKTS:RMYHY) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, analyst recommendations, profitability and dividends.

Analyst Ratings

This is a summary of current recommendations and price targets for GeneDx and Ramsay Health Care, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GeneDx	0	2	6	0	2.75
Ramsay Health Care	0	1	0	0	2.00

GeneDx currently has a consensus target price of $104.13, suggesting a potential downside of 7.82%. Given GeneDx’s stronger consensus rating and higher probable upside, equities analysts plainly believe GeneDx is more favorable than Ramsay Health Care.

Earnings and Valuation

This table compares GeneDx and Ramsay Health Care”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GeneDx	$305.45 million	10.62	-$52.29 million	$0.05	2,259.20
Ramsay Health Care	N/A	N/A	N/A	N/A	N/A

Ramsay Health Care has lower revenue, but higher earnings than GeneDx.

Volatility and Risk

GeneDx has a beta of 2.04, suggesting that its stock price is 104% more volatile than the S&P 500. Comparatively, Ramsay Health Care has a beta of 0.2, suggesting that its stock price is 80% less volatile than the S&P 500.

Institutional and Insider Ownership

61.7% of GeneDx shares are owned by institutional investors. 29.6% of GeneDx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares GeneDx and Ramsay Health Care’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
GeneDx	0.39%	16.51%	9.35%
Ramsay Health Care	N/A	N/A	N/A

Summary

GeneDx beats Ramsay Health Care on 10 of the 10 factors compared between the two stocks.

About GeneDx

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

About Ramsay Health Care

Ramsay Health Care Limited owns and operates hospitals. The company offers health care services to public and private patients. It operates facilities in approximately 530 locations in the Asia Pacific, the United Kingdom, France, and Nordics. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.